Search Results - "Toler, Tomi"

Refine Results
  1. 1
  2. 2
  3. 3

    The Exome Clinic and the role of medical genetics expertise in the interpretation of exome sequencing results by Baldridge, Dustin, Heeley, Jennifer, Vineyard, Marisa, Manwaring, Linda, Toler, Tomi L., Fassi, Emily, Fiala, Elise, Brown, Sarah, Goss, Charles W., Willing, Marcia, Grange, Dorothy K., Kozel, Beth A., Shinawi, Marwan

    Published in Genetics in medicine (01-09-2017)
    “…Purpose: Evaluation of the clinician’s role in the optimal interpretation of clinical exome sequencing (ES) results. Methods: Retrospective chart review of the…”
    Get full text
    Journal Article
  4. 4

    Expanded carrier screening for reproductive risk assessment: An evidence‐based practice guideline from the National Society of Genetic Counselors by Sagaser, Katelynn G., Malinowski, Jennifer, Westerfield, Lauren, Proffitt, Jennifer, Hicks, Melissa A., Toler, Tomi L., Blakemore, Karin J., Stevens, Blair K., Oakes, Lisa M.

    Published in Journal of genetic counseling (01-06-2023)
    “…Expanded carrier screening (ECS) intends to broadly screen healthy individuals to determine their reproductive chance for autosomal recessive (AR) and X‐linked…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    NIPT: current utilization and implications for the future of prenatal genetic counseling by Buchanan, Amanda, Sachs, Amy, Toler, Tomi, Tsipis, Judith

    Published in Prenatal diagnosis (01-09-2014)
    “…ABSTRACT Background Non‐invasive prenatal testing (NIPT) for select fetal trisomies became clinically available in 2011. When it was introduced, there were no…”
    Get full text
    Journal Article
  8. 8

    Phenotypic expansion of KMT2D‐related disorder: Beyond Kabuki syndrome by Baldridge, Dustin, Spillmann, Rebecca C., Wegner, Daniel J., Wambach, Jennifer A., White, Frances V., Sisco, Kathleen, Toler, Tomi L., Dickson, Patricia I., Cole, F. Sessions, Shashi, Vandana, Grange, Dorothy K.

    “…Pathogenic variants in KMT2D, which encodes lysine specific methyltransferase 2D, cause autosomal dominant Kabuki syndrome, associated with distinctive…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Variable cardiovascular phenotypes associated with SMAD2 pathogenic variants by Granadillo, Jorge L., Chung, Wendy K., Hecht, Leah, Corsten‐Janssen, Nicole, Wegner, Daniel, Nij Bijvank, Sebastiaan W.A., Toler, Tomi L., Pineda‐Alvarez, Daniel E., Douglas, Ganka, Murphy, Joshua J., Shimony, Joshua, Shinawi, Marwan

    Published in Human mutation (01-12-2018)
    “…SMAD2 is a downstream effector in the TGF‐β signaling pathway, which is important for pattern formation and tissue differentiation. Pathogenic variants in…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Postmortem diagnosis of very long chain acyl‐CoA dehydrogenase (VLCAD) deficiency in a neonate with sudden cardiac death by Singh, Prapti, Amaro, Deirdre, Obi, Olugbemisola, Kiran, FNU, Hediger, Erin, Toler, Tomi L., Dickson, Patricia I., Grange, Dorothy K.

    Published in JIMD reports (01-07-2023)
    “…Very long chain acyl‐CoA dehydrogenase (VLCAD) deficiency is an autosomal recessive long chain fatty acid β‐oxidation disorder with a variable clinical…”
    Get full text
    Journal Article
  14. 14

    Thoracic aortic disease in two patients with juvenile polyposis syndrome and SMAD4 mutations by Teekakirikul, Polakit, Milewicz, Dianna M., Miller, David T., Lacro, Ronald V., Regalado, Ellen S., Rosales, Ana Maria, Ryan, Daniel P., Toler, Tomi L., Lin, Angela E.

    “…Dilation or aneurysm of the ascending aorta can progress to acute aortic dissection (Thoracic Aortic Aneurysms and Aortic Dissections, TAAD). Mutations in…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Novel Presentation of a Mosaic STAT5B Gain-of-Function Variant by Schmitt, Erica, Saucier, Nermina, Risma, Samuel, Toler, Tomi, Semkiu, Katarina, Mar, Soe, Cooper, Megan

    Published in Clinical immunology (Orlando, Fla.) (01-05-2023)
    “…Somatic gain-of-function (GOF) variants in STAT5B have been described in leukemias and lymphomas, and more recently in three patients presenting with nonclonal…”
    Get full text
    Journal Article
  20. 20